BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 27974678)

  • 1. Prognostic value of increased KPNA2 expression in some solid tumors: A systematic review and meta-analysis.
    Zhou LN; Tan Y; Li P; Zeng P; Chen MB; Tian Y; Zhu YQ
    Oncotarget; 2017 Jan; 8(1):303-314. PubMed ID: 27974678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Karyopherin Alpha 2 and Karyopherin Beta 1 Correlate with Poor Prognosis in Gastric Cancer.
    Ohhara Y; Kinoshita I; Suzuki A; Imagawa M; Taguchi J; Noguchi T; Takeuchi S; Shimizu Y; Seki H; Suzuki J; Dosaka-Akita H
    Oncology; 2022; 100(12):685-695. PubMed ID: 36273446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy.
    Shi B; Su B; Fang D; Tang Y; Xiong G; Guo Z; He Q; Yang X; Zhao W; Guo Y; Li X; Zhou L
    BMC Cancer; 2015 May; 15():380. PubMed ID: 25956057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Karyopherin alpha 2 is a novel prognostic marker and a potential therapeutic target for colon cancer.
    Zhang Y; Zhang M; Yu F; Lu S; Sun H; Tang H; Peng Z
    J Exp Clin Cancer Res; 2015 Dec; 34():145. PubMed ID: 26626145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
    Müller T; Tolkach Y; Stahl D; Steiner S; Hauser S; Ellinger J; Rabien A; Ralla B; Jung K; Stephan C; Kristiansen G
    Clin Genitourin Cancer; 2019 Feb; 17(1):e167-e175. PubMed ID: 30448104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer.
    Altan B; Yokobori T; Mochiki E; Ohno T; Ogata K; Ogawa A; Yanai M; Kobayashi T; Luvsandagva B; Asao T; Kuwano H
    Carcinogenesis; 2013 Oct; 34(10):2314-21. PubMed ID: 23749771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of KPNA2 correlates with poor prognosis in patients with gastric adenocarcinoma.
    Li C; Ji L; Ding ZY; Zhang QD; Huang GR
    Tumour Biol; 2013 Apr; 34(2):1021-6. PubMed ID: 23283818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
    Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
    PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear karyopherin alpha2 expression predicts poor survival in patients with advanced breast cancer irrespective of treatment intensity.
    Gluz O; Wild P; Meiler R; Diallo-Danebrock R; Ting E; Mohrmann S; Schuett G; Dahl E; Fuchs T; Herr A; Gaumann A; Frick M; Poremba C; Nitz UA; Hartmann A
    Int J Cancer; 2008 Sep; 123(6):1433-8. PubMed ID: 18561322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy.
    Jiang P; Tang Y; He L; Tang H; Liang M; Mai C; Hu L; Hong J
    Med Oncol; 2014 Aug; 31(8):131. PubMed ID: 25031071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of anti-apoptotic protein Bcl-2 is a good prognostic factor in colorectal cancer: Result of a meta-analysis.
    Huang Q; Li S; Cheng P; Deng M; He X; Wang Z; Yang CH; Zhao XY; Huang J
    World J Gastroenterol; 2017 Jul; 23(27):5018-5033. PubMed ID: 28785155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of octamer binding transcription factor 4 for patients with solid tumors: A meta-analysis.
    Zhao X; Lu H; Sun Y; Liu L; Wang H
    Medicine (Baltimore); 2020 Oct; 99(42):e22804. PubMed ID: 33080755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KPNA2 over-expression is a potential marker of prognosis and therapeutic sensitivity in colorectal cancer patients.
    Takada T; Tsutsumi S; Takahashi R; Ohsone K; Tatsuki H; Suto T; Kato T; Fujii T; Yokobori T; Kuwano H
    J Surg Oncol; 2016 Feb; 113(2):213-7. PubMed ID: 26663089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of karyopherin 2 in human ovarian malignant germ cell tumor correlates with poor prognosis.
    He L; Ding H; Wang JH; Zhou Y; Li L; Yu YH; Huang L; Jia WH; Zeng M; Yun JP; Luo RZ; Zheng M
    PLoS One; 2012; 7(9):e42992. PubMed ID: 22962582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of karyopherin-2 in epithelial ovarian cancer and correlation with poor prognosis.
    Zheng M; Tang L; Huang L; Ding H; Liao WT; Zeng MS; Wang HY
    Obstet Gynecol; 2010 Oct; 116(4):884-891. PubMed ID: 20859152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of AGR2 expression in solid tumours: a systematic review and meta-analysis.
    Tian SB; Tao KX; Hu J; Liu ZB; Ding XL; Chu YN; Cui JY; Shuai XM; Gao JB; Cai KL; Wang JL; Wang GB; Wang L; Wang Z
    Sci Rep; 2017 Nov; 7(1):15500. PubMed ID: 29138453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Karyopherin α-2 is a reliable marker for identification of patients with high-risk stage II colorectal cancer.
    Jeong D; Kim H; Ban S; Oh S; Ji S; Kim D; Ahn TS; Kim HJ; Bae SB; Kwon HY; Im J; Lee MS; Cho HD; Kim CJ; Baek MJ
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2493-2503. PubMed ID: 28875407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of overexpressed karyopherin alpha 2 with poor survival and its contribution to interleukin-1β-induced matrix metalloproteinase expression in oral cancer.
    Wang CI; Yu CJ; Huang Y; Yi JS; Cheng HW; Kao HK; Lao WW; Chang KP
    Head Neck; 2018 Aug; 40(8):1719-1733. PubMed ID: 29542209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of karyopherin-α2 in cholangiocarcinoma correlates with poor prognosis and gemcitabine sensitivity via nuclear translocation of DNA repair proteins.
    Tsukagoshi M; Araki K; Yokobori T; Altan B; Suzuki H; Kubo N; Watanabe A; Ishii N; Hosouchi Y; Nishiyama M; Shirabe K; Kuwano H
    Oncotarget; 2017 Jun; 8(26):42159-42172. PubMed ID: 28178675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KPNA2 predicts long term survival in patients with anaplastic oligoastrocytomas.
    Gousias K; Niehusmann P; Gielen G; Simon M; Boström J
    J Clin Neurosci; 2014 Oct; 21(10):1719-24. PubMed ID: 24929863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.